About Us
ADDITIONAL EXPERIENCE
Since leaving the University system in 1989, Dr. Latham has served as Scientific Director and President of 6 additional companies, spawning multiple inventions and many commercialized products in the areas of artificial intelligence, statistical logic devices, eutectic gasses, media for culturing human stem cells, radio-protective compounds, targeted enzyme substrates, anti-viral vaccines and new chemistries for the synthesis of key synthetic intermediates and active pharmaceutical ingredients. Patents for methods of Controlled Drug Release and new drugs for treatment of Hypothyroidism, Breast Cancer, Alzheimer’s disease and Parkinson’s disease have resulted.
ADDITIONAL EXPERIENCE
Since leaving the University system in 1989, Dr. Latham has served as Scientific Director and President of 6 additional companies, spawning multiple inventions and many commercialized products in the areas of artificial intelligence, statistical logic devices, eutectic gasses, media for culturing human stem cells, radio-protective compounds, targeted enzyme substrates, anti-viral vaccines and new chemistries for the synthesis of key synthetic intermediates and active pharmaceutical ingredients. Patents for methods of Controlled Drug Release and new drugs for treatment of Hypothyroidism, Breast Cancer, Alzheimer’s disease and Parkinson’s disease have resulted.
Dr. Keith R. Latham
PROFESSIONAL EXPERIENCE
- President & Chief Scientist, ITL Pharma 1998 – Present
- Chief Scientific Officer, LIAS Research 2014-Present
- President & Chief Scientist, Innovative Technology 1996-1998
- President & Research Director, Technology Resources, Inc. 1992-1996
- President & Research Director, Inovar Biologicals and Chemicals, Inc. 1988-1992
- Professor of Medicine of the Health Sciences-Uniformed Services University-Bethesda Maryland 1977-1989
- President, BioCom Industries, Inc. 1972-1988
- Research, Factor VIII, Abbott Laboratories 1968-1972
EDUCATION
University of California at San Francisco (UCSF), Post Doctoral, Molecular Endocrinology & Pharmaceutical Chemistry, 1977
University of Southern California, PhD, Neurobiology of Aging, 1974
California State University at Los Angeles, BS, Biophysics, 1968
ACADEMIC APPOINTMENT
Uniformed Services University, Department of Medicine & Physiology (Joint), Professor of Medicine of the Health Sciences (USUHS), 1977-1989
PATENTS
ISSUED PATENTS
Sustained Drug Release and Improved Product Stability Using Non-Covalent
Particle coating Methods. (Issued 12/27/2016 Patent # 9,526,701)
Preparation of Organic Compounds for Enhanced Reactivity (issued 2/16/2016 # 9,260,380)
Halogenated Phenol Ethers for Diagnostics, Antioxidant Protection and Drug Delivery (issued 9/29/2015 Patent #8,673,269)
Halogenated Phenols for Targeted Drug Delivery (issued 9/8/2015 Patent # 9,125,946)
Preparation of Organic Compounds for Enhanced Reactivity (issued 7/21/2015 Patent # 9,085,510)
Halogenated Phenols for Diagnostics using FROS (issued 3/18/2014 Patent # 8,673,269)
Preparation, purifying, precipitation compound for subsequent reaction carried out in Suspension. (issued 6/11/2013 Patent # 8,461,381)
Polypeptide (or peptide-linked compounds) Synthesis for Drug Delivery (issued 6/4/203 Patent # 8,455,619)
Pharmaceutical composition Containing an Active agent in an Amino Acid Copolymer Structure. (issued3/28/2006 Patent # 7,018,654)
Preparation of Iodothyronine polymers (Issued 6/8/1999 Patent # 5,910,569)
Preparation of Thyroid Hormone Polymers for Treatment of Hypothyroidism (issued 6/16/1998 Patent # 5767227)
Gina Garland
Gina Garland
PROFESSIONAL EXPERIENCE
- CFO Of ITL PHARMA 2013-present
- CEO of LIAS Research 2014-present
- CEO of Valleybrook Pharmaceuticals 2013-2014
- Real Estate Broker/Auctioneer 2002-present
- Science Teacher 1989-2002
EDUCATION
Doctoral program in Science and Technology - Kent State University
M.Ed.-University of Toledo, June 1993-Major in Secondary Science
Education- Magna Cum Laude
B.S.- Baldwin Wallace College, 1989-Major in Comprehensive
Science- Cum Laude